Navigation Links
FAM Poly Caspase Assay Kit from B-Bridge International

ProductsFAM Poly Caspase Assay Kit from B-Bridge International
Company B-Bridge International
Item FAM Poly Caspase Assay Kit
Price 
Description The Poly-Caspases FLICA Apoptosis Detection Kit contains a green fluorescent-labeled inhibitor, FAM-VAD-FMK, which is a carboxyfluorescein (FAM) derivative of valylalanylaspartic acid (VAD) fluoromethyl ketone (FMK), a potent inhibitor of caspase activity. When added to a population of cells, the FAM-VAD-FMK FLICA probe enters each cell and covalently binds to a reactive cysteine residue that resides on the large subunit of the active caspase heterodimer, thereby inhibiting further enzymatic activity. Because the FAM-VAD-FMK FLICA reagent becomes covalently coupled to the enzyme, it is retained within the cell, while any unbound FAM-VAD-FMK FLICA reagent will diffuse out of the cell and is washed away. The remaining green fluorescent signal is a direct measure of the number of active caspase enzymes that were present in the cell at the time the reagent was added. Cells that contain the bound FLICA can be analyzed by 96-well-plate based fluorometry, fluorescence microscopy, or flow cytometry.
Info B-Bridge InternationalB-Bridge International
320 Logue Avenue
Mountain View, CA 94043

Customer Service: 650-969-7727
Fax Number: 650-969-7737
Web Site: http://www.b-bridge.com
NOTE: Price information is approximate list price and actual prices may vary.

Related biology products :

1. CaspaTag™ Pan-Caspase In Situ Assay Kit, Sulforhodamine from CHEMICON
2. CaspaTag™ Pan-Caspase In Situ Assay Kit, Fluorescein from CHEMICON
3. Human Caspase-7 from Calbiochem
4. In Situ Pan-Caspase Assay Kit, Sulforhodamine from CHEMICON
5. In Situ Pan-Caspase Assay Kit from CHEMICON
6. Death Check III Assay System (Caspase/Cell Viability) from Promega
7. Death Check I Assay System (TUNEL/Caspase) from Promega
8. CaspGLOW Red Caspase Staining Kit from BioVision
9. CaspSCREEN Caspase Screening Kit from BioVision
10. Caspase Inhibitor Ac-DEVD-CHO, Unconjugated from Promega
11. Rat Caspase-3 Active from BioVision
Psoralen from Sigma-Aldrich
CleanBox DNA Workstation from Bio-Rad
Mouse Anti-Human VRK2 Monoclonal Antibody, Unconjugated, Clone 3B10 from Abnova Corporation
Mouse Anti-Human PPIL2 Monoclonal Antibody, Unconjugated, Clone 2E11 from Abnova Corporation
Biology Products:
(Date:11/4/2009)... , RIDGE, N.Y., Oct. 21 What,... to preventing accidental death resulting from pre...Parents with good intentions, however, may be unaw...protecting their teens from the ticking timebomb o...ional leader in premium-quality medical supplies, ...
(Date:11/4/2009)... , NEW YORK, Oct. 27 Global R...company and advanced R&D laboratory, today ann...ode and is prepared to actively commercialize its ...-edge biometric security offerings. ,, During t...millions of dollars to develop and deploy a series...
(Date:11/4/2009)... , SEATTLE, Nov. 4 Glencoe So...scopy Environment (OME) Consortium ( http://openm...ration with the American Society of Cell Biology,s...ibrary." The ASCB has been awarded a $2.5M stimulu...s (NIH) Grand Opportunities program, as part of th...
Breaking Biology News(10 mins):MEDNET Launches MedSafe to Prevent Teenage Prescription Drug Abuse 2MEDNET Launches MedSafe to Prevent Teenage Prescription Drug Abuse 3Global Rainmakers Brings Cutting-Edge Biometric Security Products to Reality 2Global Rainmakers Brings Cutting-Edge Biometric Security Products to Reality 3Glencoe Software to Support the ASCB 'Stimulus Grant' to Build Virtual Image Library of the Cell 2Merrimack Pharmaceuticals Initiates Enrollment in a Phase 1 2 Study of MM 111 a Bispecific Antibody to ErbB2 3 50725 1Merrimack Pharmaceuticals Initiates Enrollment in a Phase 1 2 Study of MM 111 a Bispecific Antibody to ErbB2 3 50725 2Merrimack Pharmaceuticals Initiates Enrollment in a Phase 1 2 Study of MM 111 a Bispecific Antibody to ErbB2 3 50725 3Merrimack Pharmaceuticals Initiates Enrollment in a Phase 1 2 Study of MM 111 a Bispecific Antibody to ErbB2 3 50725 4McCaughey Urges Use of First NYS Hospital Infection Report 4681 1Bad medicine 50722 1
...iversity of Georgia scientists suggests that curbi... little ?if anything ?to reduce rates of antibioti...reaten human health. , Dr. Margie Lee, professor ... colleagues have found that chickens raised on ant...stine laboratory conditions have high levels of ba...
...ed wormlike insects that nibble on the plant,s lea...an fly larvae that survive eventually evolve metho... and USDA-Agriculture Research Service scientists ...n fly genes that nullify toxins that wheat produce...researchers report their findings in the Feb. 6 is...
... of action, such as Unreal Tournament, can actuall...rsity of Rochester have shown that people who play...he course of a month improved by about 20 percent ...clutter—a visual acuity test similar to ones used ...playing video game improves your bottom line on a ...
Other Biology News:Study finds antibiotic resistance in poultry even when antibiotics were not used 2Study finds antibiotic resistance in poultry even when antibiotics were not used 3Scientists find genes involved in the battle between Hessian flies and wheat 2Scientists find genes involved in the battle between Hessian flies and wheat 3Action video games sharpen vision 20 percent 2
(Date:11/5/2009)...Nov. 5 Transgenomic, Inc...cial results for the quarter ended September 30, 2... in the tables that follow. ,, Third Quarter 2...,000 or $0.01 per share for the third quarter of 2... per share for the third quarter of 2008. ,, N...
(Date:11/5/2009)...f., Nov. 5 WaferGen Bios... developer of state-of-the-art genetic analysis sy...D. has joined the company,s Scientific Advisory Bo... commercializing novel molecular diagnostics for c... development of computational biology systems for ...
(Date:11/5/2009)... Brooke Sanders brings a new look to Pro Rep...ovember 5, 2009 -- Professional Reprographics, Ora...ompany is pleased to present Brooke Sanders to the...cs/PR specialist. The addition of Brooke to the co...ithin Professional Reprographics., , ,Brooke bring...
(Date:11/4/2009)...KVILLE, Md., Nov. 4 Zyngenia, Inc.... on next-generation antibody drug development, tod...ries A funding from New Enterprise Associates (NEA...s. The capital will be used to create novel, multi... or more biological targets with a single agent. T...
Breaking Biology Technology:Transgenomic, Inc. Reports Third Quarter 2009 Results 2Transgenomic, Inc. Reports Third Quarter 2009 Results 3Transgenomic, Inc. Reports Third Quarter 2009 Results 4Transgenomic, Inc. Reports Third Quarter 2009 Results 5Transgenomic, Inc. Reports Third Quarter 2009 Results 6Transgenomic, Inc. Reports Third Quarter 2009 Results 7WaferGen Names Christopher Sears, Ph.D., Architect of High-Value Molecular Diagnostics and Computational Biology Platforms, to Company's Scientific Advisory Board 2WaferGen Names Christopher Sears, Ph.D., Architect of High-Value Molecular Diagnostics and Computational Biology Platforms, to Company's Scientific Advisory Board 3WaferGen Names Christopher Sears, Ph.D., Architect of High-Value Molecular Diagnostics and Computational Biology Platforms, to Company's Scientific Advisory Board 4Zyngenia, Inc. Raises $10 Million in Series A Funding 2Zyngenia, Inc. Raises $10 Million in Series A Funding 3Zyngenia, Inc. Raises $10 Million in Series A Funding 4